Our study highlights the significant role of the FKBP10/prelamin A/lamin A axis in regulating nuclear atypia, facilitating muscle invasion in BC, thus revealing it as a promising therapeutic target for BC. The gene discussed is FKBP10; the disease is breast cancer.